CLS future-proofs its core technology for MRI-guided laser ablation in a new agreement with IGT
Lund, Sweden – Clinical Laserthermia Systems AB (publ) (CLS) today announces that a new agreement has been signed with its supplier Image Guided Therapy SA (IGT). Under the terms of the agreement, CLS will acquire all rights to IGT's technology for MRI-based temperature measurement and control of laser-based tissue ablation.The agreement is an important part of the development of the company's technology platform and business strategy. The agreement with IGT means that CLS now owns all rights to its product portfolio and can thus fully secure value creation in the continued work with